Effect of intra-operative magnesium supplementation on plasma antioxidant levels, trace elements and electrolyte balance in serum of coronary artery bypass graft patients

Journal of Clinical and Basic Cardiology

Volumn 10, Issue 1-4, 2007, Pages 11-15

  Kurian, Gino A ^a,c   Paddikkala, J ^b  

^a MADRAS MEDICAL MISSION HOSPITAL   (India)

^b Department of Biotechnology   (India)

^c SASTRA UNIVERSITY   (India)

Author keywords

CABG; Copper; Iron; Magnesium; Myocardial ischaemia reperfusion; Zinc

Indexed keywords

CERULOPLASMIN; COPPER; CREATINE KINASE MB; IRON; LACTATE DEHYDROGENASE; MAGNESIUM; POTASSIUM; SODIUM; TRACE ELEMENT; TROPONIN I; ZINC;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; ELECTROLYTE BALANCE; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SUPPLEMENTATION; SURGICAL PATIENT; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 54249090820     PISSN: 15612775     EISSN: 16809386     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 1985; 76: 1713-9.
2. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part I. Circulation 2001; 104: 2981-9.
3. Verma S, Fedak PM, Butany J, Maitland A, Dhillon B. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002; 105: 2332-6.
4. Poltronieri R, Cevese A, Sbarbati A. Protective effect of selenium in cardiac ischemia and reperfusion. Cardioscience 1992; 3: 155-60.
5. + overload in ischemic/reperfused hearts. Eur J Pharmacol 2004; 19: 179-87.
6. De Lorgeril M, Salen P. Selenium and antioxidant defenses as major mediators in the development of chronic heart failure. Heart Fail Rev 2006; 11: 13-7.
7. Zuo XL, Chen JM, Zhou X, Li XZ, Mei GY. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res 2006; 114: 41-54.
8. Lynch SM, Frei B. Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein. J Lipid Res 1993; 34: 1745-53.
9. Oster O, Dahm M, Oelert H. Element concentrations (selenium, copper, zinc, iron, magnesium, potassium, phosphorous) in heart tissue of patients with coronary heart disease correlated with physiological parameters of the heart. Eur Heart J 1993; 14: 770-4.
10. Antila H, Salo M, Nanto V, Irjala K, Brenner R, Vapaavuori M. Serum iron, zinc, copper, selenium, and bromide concentrations after coronary bypass operation. JPEN J Parenter Enteral Nutr 1990; 14: 85-9.
11. Wardman P, Candeias LP. Fenton chemistry: an introduction. Radiat Res 1996; 145: 523-31.
12. Polderman KH, Girbes AR. Severe electrolyte disorders following cardiac surgery: a prospective controlled observational study. Crit Care 2004; 8: R459-R466.
13. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389-94.
14. Rotruck JT, Pope AL, Ganther HE, Swanson AB. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 585-90.
15. Buffone GJ, Brett EM, Lewis SA. Limitations of immunochemical measurement of ceruloplasmin. Clin Chem 1979; 25: 749-51.
16. Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for SOD. J Biol Chem 1972; 247: 3170-5.
17. Yagi K. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Free Radical Antioxidant Protocols 1998; 108: 101-6.
18. Larue C, Calzolari C, Bertinchant JP, Leclercq F, Grolleau R, Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993; 39: 972-9.
19. Osaka M, Aoyagi K, Hirakawa A, Nakajima M, Jikuya T, Shigeta O, Sakakibara Y. Comparison of hydroxyl radical generation in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass. Free Radical Res 2006; 40: 127-33.
20. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drugs Ther 1991; 5 (Suppl 2): 249-68.
21. Marczin N, El-Habashi N, Hoare GS, Bundy RE, Yacoub M. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch Biochem Biophys 2003; 420: 222-36.
22. Mates JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000; 153: 83-104.
23. Pechan I, Olejarova I, Danova K, Fischer V, Minarova H, Dobisova A, Halcak L, Rendekova V, Gabauer I. Antioxidant status of patients after on-pump and off-pump coronary artery bypass grafting. Bratisl Lek Listy 2004; 105: 45-50.
24. Luyten CR, van Overveld FJ, De Backer LA, Sadowska AM, Rodrigus IE, De Hert SG, De Backer WA. Antioxidant defense during cardiopulmonary bypass surgery. Eur J Cardiothorac Surg 2005; 27: 611-6.
25. Ueyama K, Nishimura K, Nishina T, Nakamura T, Ikeda T, Komeda M. PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery. ASAIO Journal 2004; 50: 369-72.
26. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53: 135-59.
27. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119: 598-620.
28. Chevion M. A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radic Biol Med 1988; 5: 27-37.
29. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001; 54: 176-86.
30. Atanasiu RL, Stea D, Mateescu MA, Vergely C, Dalloz F, Briot F, Maupoil V, Nadeau R, Rochette L. Direct evidence of caeruloplasmin antioxidant properties. Mol Cell Biochem 1998; 189: 127-35.
31. Nadler JL, Rude RK. Disorders of magnesium metabolism. Endocrinol Metab Clin North Am 1995; 24: 623-41.
32. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984; 108: 188-93.
33. Altura BM, Altura BT. Influence of magnesium on drug-induced contractions and ion content in rabbit aorta. Am J Physiol 1971; 220: 938-44.
34. Garcia LA, Dejong SC, Martin SM, Smith RS, Buettner GR, Kerber RE. Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model. J Am Coll Cardiol 1998; 32: 536-9.
35. Shattock MJ, Hearse DJ, Fry CH. The ionic basis of the anti-ischemic and anti-arrhythmic properties of magnesium in the heart. J Am Coll Nutr 1987; 6: 27-33.
36. Polderman KH, van Zanten AR, Girbes AR. The importance of magnesium in critically ill patients: a role in mitigating neurological injury and in the prevention of vasospasms. Intensive Care Med 2003; 29: 1202-3.
37. Brown WR, Moody DM, Challa VR, Stump DA, Hammon JW. Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli. Stroke 2000; 31: 707-13.